Effect of rising chemotherapy costs on the cost savings of colorectal cancer screening.
about
Colorectal cancer development and advances in screeningRole of Urinary Biomarkers in the Diagnosis of Adenoma and Colorectal Cancer: A Systematic Review and Meta-AnalysisEstimating colorectal cancer treatment costs: a pragmatic approach exemplified by health insurance data from GermanyPublic health impact of achieving 80% colorectal cancer screening rates in the United States by 2018Study protocol: population screening for colorectal cancer by colonoscopy or CT colonography: a randomized controlled trial.The societal gain of medical development and innovation in gastroenterology.Disease prevention: saving lives or reducing health care costs?Cost-effectiveness of colonoscopySeptin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer.Cost-effectiveness of colorectal cancer screening - an overview.Community contextual predictors of endoscopic colorectal cancer screening in the USA: spatial multilevel regression analysis.Eight years of colonoscopic bowel cancer screening in Germany: initial findings and projections.Simulation of colorectal cancer screening: what we do and do not know and does it matter.Tumor markers in colorectal cancer, gastric cancer and gastrointestinal stromal cancers: European group on tumor markers 2014 guidelines updateComparative economics of a 12-gene assay for predicting risk of recurrence in stage II colon cancerColorectal cancer screening in an equal access healthcare systemColorectal cancer: CT colonography and colonoscopy for detection--systematic review and meta-analysis.How much colonoscopy screening should be recommended to individuals with various degrees of family history of colorectal cancer?Costs and cost-effectiveness of full implementation of a biennial faecal occult blood test screening program for bowel cancer in Australia.Productivity savings from colorectal cancer prevention and control strategies.Cost-effectiveness of population-based screening for colorectal cancer: a comparison of guaiac-based faecal occult blood testing, faecal immunochemical testing and flexible sigmoidoscopy.Impact of comorbidity on colorectal cancer screening cost-effectiveness study in diabetic populations.Costs and benefits of an organized fecal immunochemical test-based colorectal cancer screening program in the United States.Eliminating cost-sharing requirements for colon cancer screening in Medicare.Identification of metastasis-associated genes in colorectal cancer using metaDE and survival analysisEfficacy of a Telehealth Intervention on Colonoscopy Uptake When Cost Is a Barrier: The Family CARE Cluster Randomized Controlled TrialAdvances in Fecal Tests for Colorectal Cancer ScreeningHow does early detection by screening affect disease progression? Modeling estimated benefits in prostate cancer screening.Cost-effectiveness of one versus two sample faecal immunochemical testing for colorectal cancer screening.Economic studies in colorectal cancer: challenges in measuring and comparing costs.Comparing cancer care, outcomes, and costs across health systems: charting the course.Bcl-xL is an oncogenic driver in colorectal cancer.Cancer prevention health services research: an emerging field.Colorectal cancer screening: Opportunities to improve uptake, outcomes, and disparities.Enhancing adoptive immunotherapy of cancer.Population screening for colorectal cancer by flexible sigmoidoscopy or CT colonography: study protocol for a multicenter randomized trial.Economic evaluation of capecitabine as adjuvant or metastatic therapy in colorectal cancer.A public-health perspective on screening colonoscopy.Serum tests for colorectal cancer screening.Cost-effectiveness of CT colonography.
P2860
Q26739885-71CF6473-98A8-4044-8B78-A26398C9E896Q28067664-9D4D77E8-7D9B-41ED-81EF-5AAF1F846E0AQ28539886-38BB4F2D-D568-40BC-B8DE-C35752C7E275Q30487713-303F8B3B-B1B3-48CC-A7C4-BDBB4E1E2B77Q33581293-1062846A-1E16-4D49-9C16-430885039CC4Q33695447-CDAB8AFB-31E0-464F-AAAD-6B8970DA9B1EQ34035101-3B5E955F-5E26-47C7-8E8B-E672619B63A3Q34094196-9AD09879-765B-476D-BC24-2FB1364A96C5Q34100603-74E22D0D-0270-4DBF-A932-F5EFE2B40112Q34125840-719F8A1C-327F-4CA5-951F-823A3A608F86Q34138849-3AAF4556-AF09-4623-9388-53F89139D28BQ34316723-A139E86D-E928-49AA-8493-8E11D152F27EQ34342290-F33F35D0-0009-4046-ADDF-2DE8E3DA5AA9Q34441837-4C72E17E-1F38-4E17-B9E2-508D15088D9DQ34573853-0931ECF8-3D85-43CF-AB2D-0AF61DB058D3Q34608026-2E65AE6E-C3F7-4379-B6AC-5A1F05DD3DB6Q34627714-A3D5A680-624B-4C98-84F2-E4EDFC493FB8Q35046586-D7CDA21C-D7E0-41DF-879F-5E51945903D6Q35106644-40840808-15FD-4457-AB87-8B6A528E2D08Q35116457-DD330C0A-96AA-46C9-8C24-FC8B2B4232F5Q35835091-091479B9-23CD-41DE-8940-1949A1546BA1Q35980669-6F2B7C43-BA6B-4473-A145-B6EBE2E490D8Q36120135-7533D525-A37A-41F2-B04F-EBFF2FD8124DQ36121783-C1080119-A4EB-4313-8856-452547811742Q36502358-557580A5-BC15-4943-B870-1581206B608FQ36525002-B3B1BB5C-CB28-4215-9BBB-18C5D8AF452EQ36665695-C84D7F8F-E74E-4115-A408-DD6AF239C4ABQ36680576-005D37C4-6BDA-4DEB-B092-E812ADED9CE5Q36745822-0161BD77-16C3-4BE7-9FE7-9EDB2C737236Q37383663-E883FADC-1BD0-465C-A4FF-CB38AF878FB9Q37383675-C4B0FE57-C0B6-45C4-A4E5-82E086088C5AQ37412492-146261E4-FFEC-48E9-8A8A-4B0718F3C0CAQ37430795-11F83688-932A-4A3A-B25C-A3B1EA45EAFDQ37507961-6FB2D29F-D1F5-489A-96D2-369A1C05E5E1Q37687429-D26D9223-1565-43F8-A458-8E9FEEEEEBADQ37688398-4870B343-0200-45EF-BD5E-52FF9618019AQ37729193-06824E31-CC47-4CC3-B835-A6FBBDEEB950Q37866788-6391D09B-3C9A-452B-9F3E-37476AC5CB85Q37902210-74B34653-6CF0-4336-A483-10D8B0B9806DQ38062641-CDF565BA-0DF6-43AC-8366-3C5364A3C23C
P2860
Effect of rising chemotherapy costs on the cost savings of colorectal cancer screening.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 September 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Effect of rising chemotherapy costs on the cost savings of colorectal cancer screening.
@en
Effect of rising chemotherapy costs on the cost savings of colorectal cancer screening.
@nl
type
label
Effect of rising chemotherapy costs on the cost savings of colorectal cancer screening.
@en
Effect of rising chemotherapy costs on the cost savings of colorectal cancer screening.
@nl
prefLabel
Effect of rising chemotherapy costs on the cost savings of colorectal cancer screening.
@en
Effect of rising chemotherapy costs on the cost savings of colorectal cancer screening.
@nl
P2860
P50
P356
P1476
Effect of rising chemotherapy costs on the cost savings of colorectal cancer screening.
@en
P2093
Ann G Zauber
J Dik F Habbema
P2860
P304
P356
10.1093/JNCI/DJP319
P407
P577
2009-09-24T00:00:00Z